[more than 13% of patients with advanced NSCLC and an aSV] "would have experienced a meaningful delay of several weeks or more if RNA-NGS and DNA-NGS had been performed sequentially rather than ...
Automated library preparation is critical for reducing errors, increasing repeatability, and reducing hands-on time, allowing researchers to generate sequence data from DNA more quickly. The CyBio ...
The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
News-Medical.Net on MSN
Study finds high intake of ultra-processed foods tied to reduced DNA methylation
Women who consumed more ultra-processed foods (UPFs) showed distinct DNA methylation patterns, mostly reduced across key gene ...
Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Residual DNA Testing Market - A Global and Regional Analysis: Focus on Offering, Test Type, Technology, Application, End User, Country, and Region - ...
The NGS panel, which has been validated on the Illumina sequencer, enables highly sensitive and specific detection of over 6,500 DNA mutations in 61 clinically relevant genes and been found to be the ...
The Global DNA Sequencing Market was valued at USD 14.8 Billion in 2024, and is expected to reach USD 34.8 Billion by 2029, rising at a CAGR of 18.60%. The report highlights the current and future ...
Next-generation sequencing (NGS) is increasingly employed to dive deeper into complex biological mechanisms in a myriad of disciplines. But as with most methodologies, the quality of the input ...
Twist Bioscience is advancing synthetic DNA manufacturing with innovation but remains at the lower end of its 52-week range.
SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, a leader in next-generation cell-free DNA manufacturing, today announced a 25% reduction in price for ENFINIA™ DNA, making industry-leading long, complex, ...
"Fueled by advances in NGS and precision medicine, China’s DNA sequencing market sees rapid growth amid strong government support, rising clinical applications, and innovation hubs in Guangdong, ...
GUILDFORD, SURREY / ACCESSWIRE / September 23, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback